. Application of additional GEMM signatures to PETACC-3 dataset. The GEMM Apc (A-C) Tp53 (D-F) and Braf (G-I) signatures were applied to the PETACC-3 dataset as described in Figure 5 , and OS, RFS, and SAR were compared. Figure S3 . Application of additional GEMM signatures to GSE14333 dataset. The GEMM Apc (A-C) Tp53 (D-F) and Braf (G-I) signatures were applied to the GSE14333 dataset as described in Figure 5 , and OS, RFS, and SAR were compared. Table S1 . List of allelic combinations represented in primary GEMM tumors analyzed.
Description of alleles present in each primary tumor analyzed, as well as numbers of each group and abbreviations. Tables S2-S3 . Enrichment analysis using shared GEMM allele specific multivariable genes from multivariable analysis. Results of MSigDB Analysis using shared multivariable gene lists from the Venn diagram in Figure 2 , including shared upregulated Kras and Braf genes (Table S2) Figure 2 , including Kras (Table S4) , Braf (Table S5) , Apc (Table   S6 ) and Tp53 (Table S7) .
Tables S8-S11. List of top 100 up and downregulated genes which constitute the GEMM allelic gene signatures for Kras, Braf, Apc, and Tp53, respectively. Table S12 . Clinical characteristics associated with the GEMM Kras signature. The GEMM Kras signature was used to determine levels of enrichment within each particular clinical annotation in the PETACC-3dataset. estimated survival probability
